| Autor: |
Carlos Real, Carlos Ferrera, María Eugenia Vázquez-Álvarez, Mike Huanca, Francisco J. Noriega, Enrique Gutiérrez-Ibañes, Ana María Mañas-Hernández, Noemí Ramos-López, Miriam Juárez, Pilar Jiménez-Quevedo, Jaime Elízaga, Ana Viana-Tejedor, Pablo Salinas |
| Jazyk: |
English<br />Spanish; Castilian |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
REC: Interventional Cardiology (English Ed.), Vol 6, Iss 3, Pp 172-181 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2604-7322 |
| DOI: |
10.24875/RECICE.M24000452 |
| Popis: |
ABSTRACT Introduction and objectives: Most patients with acute pulmonary embolism (PE) receive anticoagulation only. Reperfusion is required in high-risk and a minority of intermediate-risk PE patients. Systemic thrombolysis (ST) is the first-line reperfusion therapy, but due to contraindications and major bleeding concerns, the use of catheter-directed therapies (CDT) is increasing as a suitable alternative. The objective of the present study was to detect predictors of the use of CDT compared with other therapies in patients with acute PE. Methods: This registry included consecutive intermediate- and high-risk PE patients in 2 tertiary centers with a 24/7 PE response team from 2014 to 2022. The patients were grouped according to the primary treatment: anticoagulation only, CDT, or ST. We evaluated predictors of treatment assignment and safety endpoints. Results: A total of 274 patients were included. Of them, 112 received anticoagulation only, 96 received ST as the primary treatment, and 66 underwent CDT first. Comorbidities were higher in the CDT group than in the other 2 groups. Patients undergoing ST/CDT had higher PE severity parameters at hospital admission. On multivariable analysis, independent predictors for the use of CDT were Charlson Comorbidity Index (OR, 1.29; 95%CI, 1.05-1.59), recent surgery (OR, 11.07; 95%CI, 3.07-39.87), and bilateral central PE (OR, 2.42; 95%CI, 1.10-5.32). Analysis of early safety outcomes showed that intracranial bleeding occurred only in the ST group (1.8% of patients). Conclusions: This contemporary registry used CDT as the primary treatment in 24% of intermediate- and high-risk patients, mainly in comorbid and postsurgical patients. CDT was a safe and effective alternative to medical therapy in selected patients. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
